Anemia of inflammation

G Weiss, T Ganz, LT Goodnough - Blood, The Journal of the …, 2019 - ashpublications.org
Anemia of inflammation (AI), also known as anemia of chronic disease (ACD), is regarded
as the most frequent anemia in hospitalized and chronically ill patients. It is prevalent in …

Mitochondrial ROS regulation of proliferating cells

L Diebold, NS Chandel - Free Radical Biology and Medicine, 2016 - Elsevier
Once thought of exclusively as damaging molecules, reactive oxygen species (ROS) are
becoming increasingly appreciated for the role they play in cellular signaling through redox …

Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines

M Aapro, Y Beguin, C Bokemeyer, M Dicato… - Annals of …, 2018 - annalsofoncology.org
Anaemia and iron deficiency (ID) are frequent complications in patients with solid tumours or
haematological malignancies, particularly in patients treated with chemotherapeutic agents …

Regulation of erythropoiesis by hypoxia-inducible factors

VH Haase - Blood reviews, 2013 - Elsevier
A classic physiologic response to systemic hypoxia is the increase in red blood cell
production. Hypoxia-inducible factors (HIFs) orchestrate this response by inducing cell-type …

Physiology and pharmacology of erythropoietin

W Jelkmann - Transfusion Medicine and Hemotherapy, 2013 - karger.com
Human erythropoietin (Epo) is a 30.4 kDa glycoprotein hormone composed of a single 165
amino acid residues chain to which four glycans are attached. The kidneys are the primary …

Hypoxic regulation of erythropoiesis and iron metabolism

VH Haase - American Journal of Physiology-Renal …, 2010 - journals.physiology.org
The kidney is a highly sensitive oxygen sensor and plays a central role in mediating the
hypoxic induction of red blood cell production. Efforts to understand the molecular basis of …

Erythropoietin or darbepoetin for patients with cancer

T Tonia, A Mettler, N Robert… - Cochrane database …, 2012 - cochranelibrary.com
Background Anaemia associated with cancer and cancer therapy is an important clinical
factor in the treatment of malignant diseases. Therapeutic alternatives are recombinant …

Erythropoietin‐mediated tissue protection: reducing collateral damage from the primary injury response

M Brines, A Cerami - Journal of internal medicine, 2008 - Wiley Online Library
In its classic hormonal role, erythropoietin (EPO) is produced by the kidney and regulates
the number of erythrocytes within the circulation to provide adequate tissue oxygenation …

A network pharmacology approach to investigate the blood enriching mechanism of Danggui buxue Decoction

XQ Shi, SJ Yue, YP Tang, YY Chen, GS Zhou… - Journal of …, 2019 - Elsevier
Abstract Ethnopharmacological relevance Danggui buxue Decoction (DBD) has been
frequently used to treat with blood deficiency, which consisted of Danggui (DG) and Huangqi …

Erythropoietin: a hormone with multiple functions

M Lombardero, K Kovacs, BW Scheithauer - Pathobiology, 2011 - karger.com
Erythropoietin (EPO), the main hemopoietic hormone synthesized by the kidney as well as
by the liver in fetal life, is implicated in mammalian erythropoiesis. Production and secretion …